Sudeep Pharma Limited

₹1,178As of Sun 8 Nov 2026, 12:00 UTC
NSE:SUDEEPPHRMHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR —
Div yield 0.13%
ROE 22.04%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) —
PE TTM 71.00
TSR TTM —
Mkt cap ₹133.1B
ROIC 17.81%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹1,328
12.74%
(87.45%)
Hold 6|6|12|1|11
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
16.72
17.97
17.92
19.90
7.58%
16.23%
8.47%
15.87%
Revenue₹B
6.198
6.312
6.592
6.445
10.67%
11.46%
15.42%
9.15%
Peers (US$1.414B)
Cap (US$)
PE
1.686B
12.63x
1.576B
42.18x
1.194B
30.83x
1.428B
13.47x
Capital
TTM
5Y
10Y
Leveragex
3.271
0.066
0.063
EBIT/Intx
0.358
0.523
0.458
Own earn%
16.99
105.75
113.41
Sh yield%
40.42
50.61
44.68
Owners
Insiders/Inst%
14.08
49.96
Short interest%
0.94
SBC / revenue%
2.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
15–20
$1 testx
—
Incr. ROIC%
13